'CanChew' is Being Used in Clinical Trials for Patients with IBS
Laura McQuarrie — February 7, 2017 — Lifestyle
References: canchewgum & cannabis-samen
AXIM Biotechnologies, Inc. is the company behind CanChew Plus, a chewing gum that contains both heart-healthy hemp oil and cannabidiol, or CBD. Some of the features and benefits of the gum product include that no prescription is needed to acquire it, it is available in all 50 states, it is non-habit forming and boasts no artificial sweeteners or preservatives in its non-GMO, gluten-free and vegan formula.
Most interestingly, AXIM Biotechnologies, Inc.'s CanChew Plus is now being used as part of a clinical trial with patients who have been diagnosed with irritable bowel syndrome (IBS), a disease that affects up to 15% of the world population. Throughout the trial, participants are being asked to use the chewing gum product to manage cramping, pain and bloating that is associated with their condition.
Most interestingly, AXIM Biotechnologies, Inc.'s CanChew Plus is now being used as part of a clinical trial with patients who have been diagnosed with irritable bowel syndrome (IBS), a disease that affects up to 15% of the world population. Throughout the trial, participants are being asked to use the chewing gum product to manage cramping, pain and bloating that is associated with their condition.
2.9
Score
Popularity
Activity
Freshness
